Compare ADMA Biologics Inc (ADMA) vs AngloGold Ashanti Limited (AU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs AngloGold Ashanti Limited — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while AngloGold Ashanti Limited trades at $100.68 (market cap $49.28B). The key difference: AngloGold Ashanti Limited is far larger — about 22.2× ADMA Biologics Inc's market cap, and AngloGold Ashanti Limited pays a 4.64% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | AU | |
|---|---|---|
Market Cap | $2.22B | $49.28B |
Sector | Health | Basic Materials |
52-Week High | $20.38 | $128.26 |
52-Week Low | $7.60 | $52.15 |
Enterprise Value | $2.29B | $48.29B |
Dividend Yield | — | 4.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →
